Zuoli Pharmaceutical (300181.SZ) released results for the first three quarters, with net profit of 495 million yuan to mother, a year-on-year decrease of 3.00%

Zhitongcaijing · 2d ago

According to the Zhitong Finance App, Zoli Pharmaceutical (300181.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 2.51 billion yuan, an increase of 10.10% over the previous year. Net profit attributable to shareholders of listed companies was 495 million yuan, a year-on-year decrease of 3.00%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 496 million yuan, a year-on-year decrease of 2.42%.